Ecofarmacovigilancia: el efecto de los medicamentos sobre el medio ambiente

Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia. A Randomized Clinical Trial

Suspected Adverse Drug Reactions of Rivaroxaban Reported in the United States Food and Drug Administration Adverse Event Reporting System Database: a pharmacovigilance study

Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts

Controlling Prescribing through “Preferred Drug” Targets—The Bavarian Experience

Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

New Approach Methodologies (NAMs) in Drug Safety Assessment: A Vision of the Future

Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database

Comparative sensitivity of laboratory animals used for preclinical convulsion risk assessment to drug-induced convulsion

Misalignment between the evidence base and Scheme design

Risk of myocardial infarction in users of third generation oral contraceptives

Balancing Efficacy and Tolerability: Assessing Treatment Impact and Side Effects in Prescribing Decisions

Integration and development of veterinary Chinese medicine insight into the development of human Chinese medicine

Safety and Pharmacovigilance in Emergency Research Response

Assessment of drug therapy problems among hypertensive patients at integral institute of medical science and research

Concomitant Administration of Psychotropic and Prostate Cancer Drugs: A Pharmacoepidemiologic Study Using Drug–Drug Interaction Databases

Managing Drug-Drug Interactions and Contraindications with Cephalosporins

Global burden of ADHD medication-associated cardiovascular disease, 1967-2023: A comparative analysis using the WHO pharmacovigilance database

Radio frequency identification technology; A method of analysis of falsified pharmaceutical products: Literature review

Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS)

Off‑label and unapproved pediatric drug utilization: A meta‑analysis

Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs

Drug exposure characteristics and related pregnancy outcomes in pregnant women: an observational cohort study

The impact of emergency medicine pharmacists on medication safety for critically ill patients in the resuscitation area of an emergency department: a pilot study

La importancia de la farmacovigilancia con enfoque en las enfermedades crónico degenerativas más comunes en México

Pancreatitis Associated With Teduglutide: A Disproportionality Analysis via the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

A field-portable technology for illicit drug discrimination via deep learning of hybridized reflectance/fluorescence spectro-scopic fingerprints

The Rising Threat of Counterfeit GLP-1 Receptor Agonists: Implications for Public Health

In Vitro Assessment of Inhibitory Effects of Kinase Inhibitors on CYP2C9, 3A and 1A2: Prediction of Drug-Drug Interaction Risk with Warfarin and Direct Oral Anticoagulants

Global Perspective of the Risks of Falsified and Counterfeit Medicines: A Critical Review of the Literature

Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study

Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis

From Botox Party to Botulism: A Case Report and Public Health Warning on Adulterated Botulinum Toxin Injection

Risk factors of passive suicidal ideation among outpatients in traditional medicine clinics: the case of Korean medicine in South Korea

Risk Factors Associated With Drug-Related Side Effects in Children: A Scoping Review

Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib

Pharmacy Accessibility and Social Vulnerability

Why the Rise of This Drug-Resistant Fungus Is Raising International Concern

Which Medications Can Cause Edema?